Pandya / Brahmer / Hidalgo Lung Cancer

Translational and Emerging Therapies
Erscheinungsjahr 2013
ISBN: 978-1-4200-2035-9
Verlag: Taylor & Francis
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 280 Seiten

Reihe: Translational Medicine

Lung cancer is the leading cause of cancer-related deaths in the United States. Filling a gap in the literature, this resource translates recent laboratory findings into practical applications for the prevention and control of lung cancer. Featuring chapters by seasoned researchers in the field, this reference reviews current advances in imaging, drug development, molecular therapeutics, genetics, immunotherapy, and chemotherapy, to stand at the forefront of technologies for patient diagnosis and treatment.

Zielgruppe

Oncologists, pulmonologists, radiation and imaging specialists, pathologists, and residents and fellows in these disciplines.

Autoren/Hrsg.

Pandya, Kishan J.

Brahmer, Julie R.

Hidalgo, Manuel

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Innere Medizin

Inhaltsverzeichnis

Molecular Biology of Lung Cancer as the Basis for Targeted Therapy. Early Clinical Trial Design Issues: Patient Populations, End Points, and Barriers. Antiangiogenic Therapy for Lung Cancer: Small-Molecule Inhibitors. Antiangiogenic Therapy for Lung Cancer: Antibodies and Other Novel Agents. Epidermal Growth Factor Receptor Inhibition in Non-Small Cell Lung Cancer. Epidermal Growth Factor Receptor Targeted Therapy-Markers of Sensitivity and Response. Other Novel Targeted Therapies in Lung Cancer. Lung Cancer Vaccines. Advances in Chemoradiation Treatment of Locoregionally Advanced Non-Small Cell Lung Cancer. Advances in the Treatment of Brain Metastases. Recent Advances in Imaging for Lung Cancer